Miraculins Inc. (MOM) - Medical Equipment - Deals and Alliances Profile

Document Sample
Miraculins Inc. (MOM) - Medical Equipment - Deals and Alliances Profile Powered By Docstoc
					                  Miraculins Inc. (MOM) - Medical Equipment - Deals and Alliances Profile
       Reference Code: GDME430D                                                                                                                   Publication Date: JUN 2013

      Company Overview                                                                                             Key Facts
      Miraculins Inc (Miraculins) is a pharmaceuticals company, based in Canada. The
                                                                                                                   Miraculins Inc., Medical Equipment, Key Facts, 2011
      company develops and commercializes diagnostic tests for Unmet Clinical Needs. It
      provides discovery and validation of cancer biomarkers for development of                                     Web Address                        www.miraculins.com
      diagnostic tools and therapeutic products. Miraculins products include PREVU Skin
                                                                                                                    Revenue (US$ million)                                     0
      Cholesterol Test and PSP94 Immunoassay for Urine Specimens. Miraculins also
      provides research and development services. The company’s testing services                                    Number of Employees                             NA
      utilizes PSP94 RUO kit. It utilizes the B.E.S.T Platform technology for screening and                         GlobalData
      identification of target proteins and peptides related to diseases. Miraculins entered
      into an agreement with Inverness Medical Innovations, Inc.

      Financial Deals Landscape
        Miraculins Inc., Medical Equipment, Deals by Type, 2007 to YTD                     Miraculins Inc., Medical Equipment, Deals By Year, 2007 to
        2013                                                                               YTD 2013

                                                                                                           6
                                                                                                                                             5
                                                                                                           5
                                                                                                                                                                        4




                                                                                            No. of Deals
                                                                                                           4
                                                                                                                              3
                                                                                                           3
                                                                                                                                                              2
                                                                                                           2
                                                                                                                      1               1
                                                                                                           1
                                                                                                                                                       0
                                                                                                           0
                                                                                                                    2007     2008    2009   2010    2011     2012      YTD
                                                                                                                                                                       2013


                                                                                           Note: Deals include all announced medical equipment deals from 2006
         Note: Deals include all announced medical equipment deals from 2006               onwards, GlobalData
         onwards, GlobalData


         Miraculins Inc., Medical Equipment, Deals By Region, 2007                         Miraculins Inc., Medical Equipment, Deals By Market, 2007
         to YTD 2013                                                                       to YTD 2013

                         20     16                                                                         14
          No. of Deals




                                                                                                           12                   13
                                                                                            No. of Deals




                         15
                                                                                                           10
                         10                                                                                    8
                         5               2         2        2        2                                         6
                                                                                                               4                              2
                         0                                                                                                                                     1
                              North     Asia-    Europe   Middle   South                                       2
                              Americ   Pacific             East     and                                        0
                                a                          and     Central                                                   In Vitro     Cardiovasc        Diabetes
                                                          Africa   Americ                                                  Diagnostics       ular             Care
                                                                     a                                                                     Devices          Devices



         Note: Deals include all announced medical equipment deals from 2006               Note: Deals include all announced medical equipment deals from 2006
         onwards, GlobalData                                                               onwards, GlobalData


        Miraculins Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013
        Year                                                        No. of Deals                                                            Deal Value (US$ million)
        2007                                                                                                                1                                                 0.46
        2008                                                                                                                3                                                  0.81
        2009                                                                                                                1                                                  0.32
        2010                                                                                                                5                                                  1.46
        2011                                                                                                               NA                                                   NA
        2012                                                                                                                2                                                  2.46
        YTD 2013                                                                                                            4                                                  1.03
        Note: Deals include all announced medical equipment deals from 2006 onwards, deal values included wherever disclosed, GlobalData




Miraculins Inc. - Medical Equipment - Deals and Alliances Profile                                                                                          Reference Code: GDME430D
Source : www.globalcompanyintelligence.com                                                                                                                                        Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Miraculins Inc., Medical Equipment, Deals By Year, 2007 to YTD 2013 ............................................................................................ 4
       Miraculins Inc., Medical Equipment Deals By Type, 2007 to YTD 2013 ............................................................................................. 6
       Miraculins Inc., Medical Equipment, Deals By Region, 2007 to YTD 2013......................................................................................... 7
       Miraculins Inc., Medical Equipment, Deals By Market, 2007 to YTD 2013 ......................................................................................... 8
       Miraculins Inc., Medical Equipment, Deals Summary, 2007 to YTD 2013 .......................................................................................... 9
       Miraculins Inc., Medical Equipment, Deal Details ............................................................................................................................. 10
          Asset Purchase............................................................................................................................................................................. 10
             Miraculins To Acquire SCOUT DS, Diabetes Screening Technology, From VeraLight ............................................................. 10
             Miraculins Completes Acquisition Of PREVU Skin Cholesterol Test From PreMD ................................................................... 12
          Partnerships.................................................................................................................................................................................. 14
             Miraculins Enters Into Licensing Agreement With Mount Sinai Hospital ................................................................................... 14
             Alere Exercises Option For Licensing Agreement With Miraculins For Endoglin Products ....................................................... 16
             Miraculins Signs A Licensing Agreement With Mount Sinai Hospital ........................................................................................ 17
             Miraculins Enters Into Co-Marketing Agreement With Pear Healthcare Solutions For PreVu ................................................... 18
             Miraculins Signs An Agreement With GenWay Biotech ............................................................................................................ 19
             Miraculins Enters Into An Agreement With Inverness Medical Innovations ............................................................................... 20
          Equity Offering .............................................................................................................................................................................. 21
             Miraculins Completes Private Placeme
				
DOCUMENT INFO
Description: Miraculins Inc (Miraculins) is a pharmaceuticals company, based in Canada. The company develops and commercializes diagnostic tests for Unmet Clinical Needs. It provides discovery and validation of cancer biomarkers for development of diagnostic tools and therapeutic products. Miraculins products include PREVU Skin Cholesterol Test and PSP94 Immunoassay for Urine Specimens. Miraculins also provides research and development services. The company’s testing services utilizes PSP94 RUO kit. It utilizes the B.E.S.T Platform technology for screening and identification of target proteins and peptides related to diseases. Miraculins entered into an agreement with Inverness Medical Innovations, Inc., a developer of consumer medical diagnostic products, for the development and commercialization of Miraculins preeclampsia technology. Miraculins is headquartered in Manitoba, Canada. Miraculins Inc. (MOM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.